Project Grant R21TR004694
Award Date
8/15/24
Completion Date
7/31/26
Dollars Obligated
$456K
Federal Agency
National Center for Advancing Translational Sciences
Awardee
Duke University (TP7EK8DZV6N5)
Federal Grant Program
93.350
Assistance Type
Project Grant
Place of Performance
Durham, NC 27710, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837), provides $438,682 to The Johns Hopkins University to conduct a multi-center observational study on silent cerebral infarction (SCI) in patients with immune thrombotic thrombocytopenic purpura (iTTP). The key objectives are to: 1) elucidate the natural history of SCI and establish the incidence and risk factors for new SCI and...
This $2,500,027 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support the development of the Tau Progression Index (TPI), a novel prognostic score that can predict tau accumulation, neurodegeneration, and cognitive/functional decline in Alzheimer's disease (AD). The key products and services to be delivered under this 5-year award include: Recruiting 130 non-demented participants with evidence of amyloid-beta and tau pathologies based on PET...
The National Center for Advancing Translational Sciences (NCATS) awarded a $429,000 Project Grant (CFDA 93.350) to The Regents of the University of Colorado (University of Colorado-Denver) to address critical gaps in enabling clinical trial readiness for the rare Posterior Cortical Atrophy (PCA) syndrome. Over a 2-year period from August 2024 to July 2026, the project aims to longitudinally assess patient-reported and informant-reported PCA-specific clinical outcome assessments (COAs),...
This $6,214,900 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program supports research on the role of genetic risk factors and immune response on neurovascular unit (NVU) function in post-traumatic brain injury (TBI) cognitive impairment. The primary awardee, the Scintillon Institute, a non-profit biomedical research organization in San Diego, California, will conduct this advanced scientific investigation over...
This $216,210 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) supports research on the potential of transcranial direct current stimulation (tDCS) as a therapeutic intervention to improve neurovascular coupling and cognitive function in stroke survivors with post-stroke cognitive impairment (PSCI). The project aims to comprehensively evaluate neurovascular coupling responses in stroke survivors with and without cognitive impairment, and conduct a...
This $110,000 Project Grant award from the National Center for Advancing Translational Sciences (NCATS) under CFDA 93.350 supports research by Greenstone Biosciences, Inc. to develop advanced drug discovery and development technologies for rare genetic disorders. The project aims to leverage induced pluripotent stem cell (iPSC) technology and artificial intelligence/machine learning (AI/ML) to accelerate and streamline the drug discovery process for myotonic dystrophy type 1 (DM1), a rare and...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $810,875 to The Trustees of the University of Pennsylvania to conduct pre-clinical research on developing chimeric antigen receptor (CAR) T cell therapies as a curative treatment for immune thrombotic thrombocytopenic purpura (iTTP), a life-threatening autoimmune disorder. The researchers are exploring two novel CAR T cell platforms that...
This federal Project Grant award, totaling $2,283,334, was provided by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866). The award was granted to the Morehouse School of Medicine (MSM) to develop and validate a progressive murine model for traumatic brain injury (TBI)-induced Alzheimer's disease and related dementias (TBI-ADRD). The key objectives of this 5-year project are to: 1) Screen diverse mouse strains and TBI injury models to identify the optimal...
This $251,250 federal Project Grant award, funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to investigate the link between traumatic brain injury (TBI) and neurodegeneration in models of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) involving the TAR DNA-binding protein 43 (TDP-43). The research will characterize...
This federal Project Grant award under CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders, provided by the National Institute of Neurological Disorders and Stroke (NINDS), totals $5,949,022 and will fund research to identify novel therapeutic targets for treating cerebral amyloid angiopathy (CAA) and vascular contributions to cognitive impairment and dementia (VCID) associated with Alzheimer's disease and related dementias. The project aims to leverage...